EODData

MEMBERSHIP REGISTER LOG IN

FRA, TGNA: Transgene SA

16 Jan 2026
LAST:

0.9200

CHANGE:
 0.02		OPEN:
0.9200		HIGH:
0.9200		ASK:
0.0000		VOLUME:
200
CHG(%):
1.71		PREV:
0.9360		LOW:
0.9200		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
16 Jan 260.92000.92000.92000.9200200
15 Jan 260.93600.93600.93600.9360200
14 Jan 260.95800.95800.95800.9580200
13 Jan 260.96600.96600.96600.9660200
12 Jan 260.93600.93600.93600.9360200
09 Jan 260.90801.01000.90801.0100200
08 Jan 260.91200.91200.91200.91208.6K
07 Jan 260.90400.90400.90400.90408.6K
06 Jan 260.90800.96600.90800.96600
05 Jan 260.92000.92000.92000.92008.6K

PROFILE

Name:Transgene SA
About:Transgene SA, a biotechnology company, designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer in France. It involved in developing TG4050, a therapeutic vaccine that is in Phase II clinical trial for the treatment of ovarian cancer, and head and neck cancers; TG4001, a therapeutic vaccine, which is in Phase II clinical trial for the treatment of human papillomavirus (HPV 16) positive cancers; TG6002, an oncolytic virus that is in Phase I/IIa clinical trial for the treatment of solid tumors, including gastrointestinal adenocarcinoma; and BT-001, an oncolytic virus, which is in Phase I/II clinical trial for the treatment of solid tumors. The company also develops TG6050 for the treatment of non-small cell lung cancer that is in Phase 1 clinical trial; and Pexa-Vec, an oncolytic virus for the treatment of solid tumors. It has strategic collaboration agreements with AstraZeneca, Merck KGaA, Pfizer, and NEC Corporation; licensing agreements with SillaJen, Ascend BioPharmaceutical, and Valneva; and agreements with Merck & Co, Sanofi, and BioInvent. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene SA is a subsidiary of TSGH SAS.
Sector:Healthcare
Industry:Biotechnology
Address:400, boulevard Gonthier d?Andernach, Illkirch-Graffenstaden, France, 67405
Website:https://www.transgene.fr
ISIN:FR0005175080

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:9.25 
Forward P/E:6.40 
Price to Sales:18.16 
Price to Book:1.00 
Operating Margin:-3.73 
Return on Assets:-0.49 
Return on Equity:-2.23 
EPS Ratio:2.09 
Revenue:7.58M 
Shares:161.06M 
Market Cap:148.17M 

TECHNICAL INDICATORS

MA5:0.942.5%
MA10:0.942.5%
MA20:0.941.6%
MA50:1.0615.2%
MA100:1.1019.7%
MA200:0.931.0%
STO9:15.09 
STO14:15.09 
RSI14:49.24
WPR14:-84.91 
MTM14:-0.08
ROC14:-0.08 
ATR:0.05 
Week High:1.019.8%
Week Low:0.911.3%
Month High:1.019.8%
Month Low:0.881.0%
Year High:1.4961.4%
Year Low:0.5567.3%